Ventus Therapeutics U.S., Inc.
🇺🇸United States
Clinical Trials
4
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (100.0%)A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease
- First Posted Date
- 2025-02-12
- Last Posted Date
- 2025-08-12
- Lead Sponsor
- Ventus Therapeutics U.S., Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT06822517
- Locations
- 🇺🇸
Investigative Site, Spokane, Washington, United States
News
No news found